Atlas Trials

Modulate Cellular Stress in the Immune Cells to Reduce Rate of Symptomatic Viral Infection

Clinical trial NCT04267809 · COMPLETED

Trial details

NCT number
NCT04267809
Sponsor
Singapore General Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Endoplasmic Reticulum StressViral InfectionYellow Fever
Start date
2021-10-22
Primary completion
2023-07-31
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.